Skip to content

Beta-blockers in heart failure with reduced ejection fraction

Reviewed by doctors · Last reviewed: November 2026▶ Play today's clinical caseMedicinedle · a Wordle-style case game · free
Advertisement
Advertisement
Chart of beta-blockers in heart failure with reduced ejection fraction: carvedilol, metoprolol succinate and bisoprolol in US and European guidelines, and nebivolol in European guidelines
⬇ Download the diagramView full size⬇ Download as PDF

Free to use for study and teaching with attribution to MIROTECA · terms of use

These are the beta-blockers shown to improve survival in heart failure with reduced ejection fraction.

More diagrams: Killip classification · NYHA functional classification · GRACE score · Stopping anticoagulants and antiplatelets before surgery

What the chart shows

Not every beta-blocker works in heart failure with reduced ejection fraction (HFrEF). Only a few have been shown to reduce mortality, and they are part of the baseline treatment.

How the question is asked

The error the exam tries to catch is giving "any" beta-blocker in HFrEF; only the agents with proven benefit serve this purpose. The other classic trap is timing: they are never started during acute decompensation with congestion, but in a stable patient without volume overload.

They are started at low doses and increased slowly ("start low, go slow") while monitoring heart rate and blood pressure. Together with ACE inhibitors or ARNI, mineralocorticoid receptor antagonists (spironolactone, eplerenone) and SGLT2 inhibitors they form the "four pillars" that improve prognosis. In heart failure with preserved ejection fraction they do not have the same prognostic benefit.

US and European guidelines differ

The Spanish version of this chart, based on European practice, lists four: carvedilol, metoprolol succinate, bisoprolol and nebivolol (useful in older adults). The 2022 AHA/ACC/HFSA guideline recommends one of three beta-blockers proven to reduce mortality: bisoprolol, carvedilol or sustained-release metoprolol succinate. For US exams, the answer is those three. Related: NYHA classification.

Keep practicing

This page is the visual summary. To test yourself with real clinical reasoning, Medicinedle, a Wordle-inspired game, gives you one clinical case a day: guess the diagnosis in six tries, with a new clue after every miss. It is free.

Play today's case →

Prefer quick questions? The clinical scores quiz gives you 5 case-based questions in about a minute, with the answer explained.

Advertisement

Related

See all medical diagrams